# Vitamin D, C-reactive Protein and Insulin Resistance

> **NCT01019642** · PHASE3 · COMPLETED · sponsor: **Instituto Nacional de Salud Publica, Mexico** · enrollment: 104 (actual)

## Conditions studied

- Diabetes
- Low-intensity Chronic Inflammation
- Insulin Resistance

## Interventions

- **DRUG:** cholecalciferol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01019642
- **Lead sponsor:** Instituto Nacional de Salud Publica, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2009-11-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01019642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01019642, "Vitamin D, C-reactive Protein and Insulin Resistance". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01019642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*